subject: CHEBI:45267

subject_name: praziquantel

object_name: schistosomiasis


subject: CHEBI:91583

subject_name: Praziquantel

tested_intervention: yes


subject: CHEBI:2663

subject_name: Amiodarone

object_name: atrial fibrillation


subject: CHEBI:2663

object_name: Atrial Fibrillation by ECG Finding


subject: CHEBI:2663

object_name: Atrial Fibrillation, CTCAE


subject: CHEBI:41423

subject_name: Celecoxib

object_name: QT INTERVAL, VARIATION IN

tested_intervention: unsure


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: PR:000014196

subject_name: eukaryotic-type large ribosomal subunit protein uL22

object_name: esophageal squamous cell carcinoma


subject: PR:000014196

object_name: Oligometastatic malignant neoplasm


subject: PR:000001919

subject_name: programmed cell death protein 1


subject: PR:000001919


subject: CHEBI:3181

subject_name: Bromocriptine

object_name: Suppressed lactation


subject: CHEBI:3286

subject_name: Cabergoline


subject: CHEBI:8378

subject_name: Prednisolone

object_name: Post-COVID-19 syndrome


subject: CHEBI:8378

object_name: long COVID-19


subject: UMLS:C1321981

subject_name: Vitamin B Compound


subject: UMLS:C1321981


subject: UMLS:C5235210

object_name: type 2 diabetes mellitus


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: papillary serous cystadenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: peritoneal carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: ovarian adenocarcinoma


subject: UNII:2S9ZZM9Q9V

object_name: fallopian tube adenocarcinoma


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: primary peritoneal carcinoma


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:16208013

subject_name: Tecemotide

object_name: non-small cell lung carcinoma


subject: UNII:Q7Y026G2CX

subject_name: TECEMOTIDE


subject: UMLS:C1832016


subject: UNII:3FTR44B32Q

object_name: Subgingival plaque


subject: UNII:3FTR44B32Q

object_name: dermatofibrosarcoma protuberans


subject: CHEBI:135933

subject_name: Tin Fluorides


subject: CHEBI:135933


subject: CHEBI:63613

subject_name: Nevirapine

object_name: outcomes general quality of life


subject: CHEBI:63613

object_name: Perceived quality of life


subject: CHEBI:63613

object_name: Good quality of life


subject: UniProtKB:P41416

subject_name: CXOL_NPVAC Conotoxin-like peptide (sprot)

object_name: Stomach cancer


subject: UniProtKB:P41416

object_name: gastric cancer


subject: UMLS:C0003442

subject_name: lymphocyte immune globulin, anti-thymocyte globulin

object_name: Fanconi anemia


subject: UMLS:C0003442

object_name: Fanconi anemia complementation group A


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara


subject: PUBCHEM.COMPOUND:3368


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:45783

subject_name: Imatinib

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:45783

object_name: Metastatic Malignant Solid Neoplasm


subject: CHEBI:45783

object_name: Metastatic Gastrointestinal Stromal Tumor


subject: CHEBI:45783

object_name: Unresectable Solid Neoplasm


subject: CHEBI:45783

object_name: C-KIT Tyrosine Kinase Protein Overexpression


subject: CHEBI:45783

object_name: Clinical Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:45783

object_name: Pathologic Stage IV Cutaneous Melanoma AJCC v8


subject: CHEBI:45783

object_name: Unresectable Melanoma


subject: CHEBI:45783

object_name: metastatic melanoma


subject: CHEBI:231679

subject_name: ipilimumab


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: CHEBI:231679


subject: UNII:A3ULP0F556

subject_name: Eculizumab

object_name: kidney failure


subject: UNII:A3ULP0F556

object_name: end stage renal failure


subject: UNII:A3ULP0F556

object_name: Chronic uremia


subject: CHEBI:30145

subject_name: lithium atom

object_name: endogenous depression


subject: CHEBI:30145

object_name: major depressive disorder


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: UNII:L2N7Z24B30


subject: CHEBI:49713

subject_name: Lithium cation


subject: CHEBI:49713


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C3540800


subject: UMLS:C5854509

subject_name: ADC 9MW2821

object_name: triple-negative breast carcinoma


subject: UMLS:C5854509

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C5207052

subject_name: Paclitaxel Albumin


subject: UMLS:C5207052


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: extranodal nasal NK/T cell lymphoma


subject: CHEBI:135918

object_name: Lymphoma, Extranodal NK-T-Cell


subject: CHEBI:71200

subject_name: Tofacitinib


subject: CHEBI:71200


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Childhood Breast Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: breast carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: breast cancer


subject: UNII:B72HH48FLU

subject_name: Infliximab

object_name: rheumatoid arthritis


subject: UMLS:C5239903

subject_name: Phesgo


subject: UMLS:C5239903


subject: UMLS:C5239903


subject: UMLS:C5239903

object_name: HER2 positive breast carcinoma


subject: CHEBI:59826

subject_name: progestin

object_name: habitual spontaneous abortion


subject: CHEBI:59826

object_name: Haemorrhage in early pregnancy


subject: UNII:6QVL057INT

subject_name: Cemiplimab

object_name: Locally Recurrent Oral Cavity Squamous Cell Carcinoma


subject: UMLS:C4053601


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0540110

subject_name: HOE 901

object_name: type 2 diabetes mellitus


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: non-small cell lung carcinoma


subject: CHEBI:52763


subject: UNII:15C2VL427D

subject_name: Aflibercept

object_name: pancreatic endocrine carcinoma


subject: UNII:15C2VL427D

object_name: Neuroendocrine carcinoma of pancreas


subject: UNII:15C2VL427D

object_name: multiple endocrine neoplasia type 1


subject: CHEBI:60648

subject_name: DOXYCYCLINE

object_name: aneurysm


subject: PUBCHEM.COMPOUND:54671203

subject_name: doxycycline


subject: CHEBI:94463

object_name: Infection


subject: CHEBI:94463

object_name: infectious disease


subject: CHEBI:94463

object_name: Adverse Event Associated with Infection


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:63580


subject: CHEBI:68595

subject_name: Telaprevir


subject: CHEBI:68595


subject: CHEBI:68595


subject: CHEBI:48390

subject_name: Cinacalcet

object_name: X-linked dominant hypophosphatemic rickets


subject: CHEBI:49005

subject_name: Deferasirox

object_name: porphyria cutanea tarda


subject: CHEBI:49005

object_name: familial porphyria cutanea tarda


subject: CHEBI:190008

subject_name: Tianeptine

object_name: bipolar disorder


subject: UMLS:C2348994

object_name: non-small cell squamous lung carcinoma


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Drooling


subject: CHEBI:135207

subject_name: Clofedanol


subject: CHEBI:15365

subject_name: Aspirin


subject: UNII:J2V5N8T1BL

object_name: Frailty


subject: UNII:J2V5N8T1BL

object_name: Sarcopenic obesity


subject: UNII:J2V5N8T1BL

object_name: kwashiorkor


subject: UMLS:C5418047

object_name: triple-negative breast carcinoma


subject: UMLS:C5418047

object_name: Triple-Negative Breast Cancer Finding


subject: CHEBI:2567

subject_name: Alendronic acid

object_name: Osteopenia/osteoporosis


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Cervical spondylosis without myelopathy


subject: CHEBI:4466

object_name: Neck Arthritis


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UNII:7N8K34P2XH


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: osteomalacia


subject: CHEBI:89324

object_name: abnormal mineralization disorder


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UMLS:C3714503


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UNII:9VU1KI44GP


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C2936842


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UMLS:C3537249


subject: UNII:F3EST236LD

object_name: type 2 diabetes mellitus


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: malignant soft tissue neoplasm


subject: UNII:PVI5M0M1GW

object_name: sarcoma


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:31824


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:17905


subject: UMLS:C0085721


subject: UMLS:C0085721


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:125400

subject_name: actinomycin D


subject: CHEBI:125400


subject: CHEBI:27666

subject_name: Dactinomycin


subject: CHEBI:27666


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: UNII:T5IRO3534A

subject_name: Oncovin


subject: UNII:T5IRO3534A


subject: PUBCHEM.COMPOUND:3717450

subject_name: Leurocristine


subject: PUBCHEM.COMPOUND:3717450


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: Unresectable Hepatocellular Carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:1P05PW62F3

subject_name: CONBERCEPT

object_name: proliferative diabetic retinopathy


subject: UMLS:C2352201

subject_name: Conbercept


subject: CHEBI:52994

subject_name: precursor Z

object_name: sulfite oxidase deficiency due to molybdenum cofactor deficiency type A


subject: CHEBI:59648

subject_name: precursor Z(1-)


subject: CHEBI:60210

subject_name: Fosdenopterin


subject: UMLS:C5443981

subject_name: Cyclic Pyranopterin Monophosphate [EXT]


subject: UMLS:C5443982

subject_name: Cyclic Pyranopterin Monophosphate [EPC]


subject: UMLS:C1703892

subject_name: Topical Phenylephrine Solution

object_name: Intraoperative Hemorrhage


subject: CHEBI:37924

subject_name: Atazanavir

object_name: HIV infection


subject: UMLS:C0700599

subject_name: pyrimethamine / sulfadoxine

object_name: malaria


subject: UMLS:C3467983

object_name: prostate carcinoma


subject: UMLS:C3467983

object_name: prostate cancer


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Recurrent Childhood Glioblastoma


subject: GTOPDB:9758

object_name: Recurrent Glioblastoma


subject: UNII:73096E137E


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UMLS:C4085979


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: UNII:2S9ZZM9Q9V


subject: CHEBI:7459

subject_name: Naloxone

object_name: opiate dependence


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent ovarian cancer


subject: CHEBI:31355

subject_name: Carboplatin


subject: UNII:DPT0O3T46P


subject: UNII:BPQ010OFD7

subject_name: RALUDOTATUG DERUXTECAN


subject: UMLS:C5555533

subject_name: Anti-CDH-6 ADC DS-6000a


subject: CHEBI:30145

subject_name: lithium atom

object_name: bipolar disorder


subject: UNII:L2N7Z24B30

subject_name: lithium orotate


subject: CHEBI:49713

subject_name: Lithium cation


subject: UMLS:C3540800

subject_name: Lithium antipsychotics


subject: UMLS:C0678449

subject_name: Cannabis substance

object_name: Psychedelic Experiences


subject: UMLS:C0678449

object_name: psychedelic drug dependence


subject: UMLS:C0678449

object_name: Psychiatric problem


subject: UMLS:C0678449

object_name: Depressed mood


subject: UMLS:C0678449

object_name: anxiety disorder


subject: UMLS:C0678449

object_name: Cancer patients and suicide and depression


subject: UMLS:C0678449

object_name: Depressed - symptom


subject: UMLS:C0678449

object_name: Depression, CTCAE


subject: UMLS:C0678449

object_name: anxiety


subject: UMLS:C0678449

object_name: Anxiety symptoms


subject: UMLS:C0678449

object_name: Anxiety, CTCAE 3.0


subject: UMLS:C0678449

object_name: Anxiety, CTCAE 5.0


subject: UMLS:C0678449

object_name: post-traumatic stress disorder


subject: UMLS:C0678449

object_name: BH4-deficient hyperphenylalaninemia A


subject: UMLS:C0024808

subject_name: Marihuana


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C0024808


subject: UMLS:C4552088

subject_name: Cannabis sativa whole extract


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: UMLS:C4552088


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: pyruvate dehydrogenase E1-alpha deficiency


subject: CHEBI:41500

object_name: pyruvate dehydrogenase deficiency


subject: CHEBI:41500

object_name: Decreased activity of the pyruvate dehydrogenase complex


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Infection of transplanted kidney


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:8499

subject_name: Propranolol

object_name: Bleeding gastric varices


subject: CHEBI:8499

object_name: liver cirrhosis


subject: GTOPDB:12347

subject_name: penpulimab

object_name: nasopharyngeal carcinoma


subject: GTOPDB:12347

object_name: nasopharyngeal carcinoma, susceptibility to, 1


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C1134664

object_name: melanoma


subject: PUBCHEM.COMPOUND:152165

object_name: otitis externa


subject: PUBCHEM.COMPOUND:152165

object_name: Otitis Externa, CTCAE


subject: CHEBI:47381

subject_name: Diclofenac


subject: CHEBI:47381


subject: CHEBI:63450

subject_name: Masitinib

object_name: metastatic colorectal cancer


subject: UMLS:C2351399


subject: CHEBI:6367

subject_name: Lamotrigine

object_name: epilepsy


subject: CHEBI:6935

subject_name: Miglitol

object_name: type 2 diabetes mellitus


subject: CHEBI:85083

subject_name: Sofosbuvir

object_name: acute hepatitis C virus infection


subject: PUBCHEM.COMPOUND:77335690

subject_name: Velpatasvir


subject: CHEBI:156543

subject_name: ammonium persulfate

object_name: osteoarthritis, knee


subject: CHEBI:17709

subject_name: Adenosine 5'-phosphosulfate


subject: CHEBI:27374

subject_name: Levoinositol

object_name: Abnormal uterine bleeding


subject: CHEBI:27372


subject: UMLS:C0022912

subject_name: Lactalbumin


subject: CHEBI:43362

subject_name: Forodesine

object_name: T-Cell Lymphoma


subject: CHEBI:43362

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:68534

subject_name: Enzalutamide

object_name: Metastatic castration-resistant prostate cancer


subject: CHEBI:76842

object_name: Slow transit constipation


subject: CHEBI:28001

subject_name: Vancomycin


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Carcinoma breast stage IV


subject: PUBCHEM.COMPOUND:73151030

subject_name: Empagliflozin

object_name: Blood Clot


subject: PUBCHEM.COMPOUND:73151030

object_name: thrombosis


subject: PUBCHEM.COMPOUND:73151030

object_name: Thrombosis of blood vessel


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin


subject: PUBCHEM.COMPOUND:74328238


subject: PUBCHEM.COMPOUND:74328238


subject: UMLS:C3714501

subject_name: Insulin Drug Class

object_name: insulin resistance in diabetes


subject: UMLS:C3714501

object_name: Wound Complication


subject: UMLS:C3714501

object_name: Wound Complication, CTCAE


subject: CHEBI:5931

subject_name: insulin human


subject: CHEBI:5931


subject: CHEBI:5931


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Recurrent Childhood Glioblastoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Glioblastoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Childhood Gliosarcoma


subject: UNII:DPT0O3T46P

object_name: Recurrent Gliosarcoma


subject: UNII:9AG41L3AOQ

subject_name: Gallium-68 PSMA

object_name: Biochemically Recurrent Prostate Carcinoma


subject: UNII:9AG41L3AOQ

object_name: Non-metastatic prostate cancer


subject: MESH:C000711993

subject_name: Ocufolin

object_name: type 2 diabetes mellitus


subject: MESH:C000711993

object_name: Diabetes


subject: MESH:C000711993

object_name: diabetes mellitus


subject: UNII:NU90V55F8I

subject_name: Sarilumab

object_name: rheumatoid arthritis


subject: PUBCHEM.COMPOUND:266052

subject_name: Vitamin

object_name: Infection


subject: PUBCHEM.COMPOUND:266052

object_name: Infection of musculoskeletal system


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: UMLS:C2348288

subject_name: Dietary Zinc


subject: UMLS:C2348288


subject: CHEBI:29105

subject_name: Velmanase alfa


subject: CHEBI:29105


subject: CHEBI:27363

subject_name: Zinc


subject: CHEBI:27363


subject: UMLS:C3541396

subject_name: Zinc Supplements


subject: UMLS:C3541396


subject: UMLS:C3714650

subject_name: Zinc Drug Class


subject: UMLS:C3714650


subject: UNII:90Z2UF0E52

subject_name: Mepolizumab

object_name: chronic rhinosinusitis without nasal polyps


subject: MESH:C510903

subject_name: fluarix

object_name: influenza


subject: PUBCHEM.COMPOUND:21628493

subject_name: ESTROGEN

object_name: Androgen excess


subject: PUBCHEM.COMPOUND:21628493

object_name: Increased circulating androgen concentration


subject: CHEBI:50114

subject_name: estrogen


subject: CHEBI:50114


subject: CHEBI:4903

subject_name: Ethinylestradiol


subject: CHEBI:4903


subject: UMLS:C2936882

subject_name: Estrogen [EPC]


subject: UMLS:C2936882


subject: CHEBI:17026

subject_name: Progesterone


subject: UMLS:C2757070

subject_name: Progesterone [EPC]


subject: UMLS:C2757070


subject: CHEBI:23965

subject_name: estradiol


subject: CHEBI:23965


subject: UNII:JD5ZWE631K

object_name: metabolic dysfunction-associated steatotic liver disease


subject: UNII:JD5ZWE631K

object_name: liver cirrhosis


subject: UNII:GN465U8B72

subject_name: Nemolizumab

object_name: poikiloderma with neutropenia


subject: UNII:GN465U8B72

object_name: prurigo nodularis


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: adult lymphoma


subject: CHEBI:168396

object_name: lymphoma


subject: CHEBI:168396

object_name: pediatric lymphoma


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:8764


subject: CHEBI:8764


subject: CHEBI:167450

subject_name: Monomethyl fumarate

object_name: hematopoietic and lymphoid system neoplasm


subject: CHEBI:167450

object_name: Myelodysplasia


subject: CHEBI:167450

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:167450

object_name: childhood myelodysplastic syndrome


subject: CHEBI:167450

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:167450

object_name: leukemia


subject: CHEBI:167450

object_name: childhood leukemia


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:167450


subject: CHEBI:9168

subject_name: Sirolimus


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: CHEBI:9168


subject: UNII:D7RD81HE4W

subject_name: thymoglobulin


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UNII:D7RD81HE4W


subject: UMLS:C0359156

subject_name: Thymoglobulin


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: UMLS:C0359156


subject: CHEBI:74705

subject_name: Met-Leu

object_name: Previous pregnancy 1


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UNII:2O4BE0K238

subject_name: Volanesorsen

object_name: familial lipoprotein lipase deficiency


subject: CHEBI:17026

object_name: abortion


subject: UMLS:C2757070


subject: UMLS:C2827518

subject_name: Oncolytic HSV1716

object_name: Childhood Neuroblastoma


subject: UMLS:C2827518

object_name: neuroblastoma


subject: UMLS:C2827518

object_name: Ewing sarcoma


subject: UMLS:C2827518

object_name: pediatric osteosarcoma


subject: UMLS:C2827518

object_name: Osteosarcoma


subject: UMLS:C2827518

object_name: Childhood Soft Tissue Sarcoma


subject: UMLS:C2827518

object_name: Adult Soft Tissue Sarcoma


subject: UMLS:C2827518

object_name: sarcoma


subject: UMLS:C2827518

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: UMLS:C2827518

object_name: soft tissue sarcoma


subject: UMLS:C2827518

object_name: malignant peripheral nerve sheath tumor


subject: UMLS:C2827518

object_name: adult malignant schwannoma


subject: UMLS:C2827518

object_name: childhood malignant schwannoma


subject: UMLS:C2827518

object_name: nephroblastoma


subject: UMLS:C2827518

object_name: Wilms tumor


subject: UMLS:C2827518

object_name: childhood kidney Wilms tumor


subject: UMLS:C2827518

object_name: Adult Rhabdomyosarcoma


subject: UMLS:C2827518

object_name: rhabdomyosarcoma


subject: UMLS:C2827518

object_name: Childhood Rhabdomyosarcoma


subject: UMLS:C2827518

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: UMLS:C2827518

object_name: clivus chordoma


subject: UMLS:C5667036

subject_name: Lipid Nanoparticle-encapsulated EBV mRNA Vaccine mRNA-1189

object_name: EBV Infection


subject: CHEBI:50924

subject_name: Sorafenib

object_name: carcinoma


subject: CHEBI:74926

subject_name: Patulin


subject: UNII:X587FW0372

subject_name: Ketone Ester

object_name: Ketosis


subject: UNII:X587FW0372

object_name: Ketoacidosis


subject: UMLS:C2587183

subject_name: RiaSTAP

object_name: blood coagulation disease


subject: CHEBI:71940

subject_name: Tadalafil

object_name: premature ejaculation


subject: CHEBI:71940

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:71940

object_name: Erectile dysfunction


subject: CHEBI:131174

subject_name: Navitoclax

object_name: B-cell chronic lymphocytic leukemia


subject: UMLS:C1831992

subject_name: ABT 263


subject: CHEBI:9123

subject_name: Sertraline

object_name: heart failure


subject: CHEBI:9123

object_name: congestive heart failure


subject: UNII:KX7K68Z2UH

subject_name: ENZASTAURIN HYDROCHLORIDE

object_name: breast neoplasm


subject: UMLS:C1765315

subject_name: Enzastaurin Hydrochloride


subject: CHEBI:9654

subject_name: Trazodone

object_name: Maternity blues


subject: PR:000022493

object_name: hepatitis C


subject: CHEBI:197268

subject_name: Tocotrienol

object_name: metabolic dysfunction-associated steatotic liver disease


subject: CHEBI:197268

object_name: Fatty Liver


subject: UNII:KP2MW85SSQ

subject_name: TOCOTRIENOLS


subject: UNII:KP2MW85SSQ


subject: UMLS:C3714803

subject_name: Vitamin E Drug Class


subject: UMLS:C3714803


subject: CHEMBL.COMPOUND:CHEMBL3989727

subject_name: VITAMIN E


subject: CHEMBL.COMPOUND:CHEMBL3989727


subject: CHEBI:18145

subject_name: Vitamin E


subject: CHEBI:18145


subject: CHEBI:94366

subject_name: itraconazole

object_name: skin basal cell carcinoma


subject: CHEBI:85662

subject_name: Lixisenatide

object_name: type 2 diabetes mellitus


subject: UMLS:C2604519


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: neuroendocrine carcinoma


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:82978

subject_name: paliperidone

object_name: schizophrenia


subject: CHEBI:188072


subject: CHEBI:83804

subject_name: Paliperidone


subject: UNII:4685R51V7M

subject_name: Esmirtazapine

object_name: Dyssomnias


subject: UNII:4685R51V7M

object_name: sleep disorder, initiating and maintaining sleep


subject: UNII:4685R51V7M

object_name: insomnia


subject: UNII:4685R51V7M

object_name: sleep disorder


subject: UNII:4685R51V7M

object_name: Sleep Disorders, Intrinsic


subject: UNII:4685R51V7M

object_name: mental disorder


subject: UNII:4685R51V7M

object_name: psychiatric disorder


subject: CHEBI:6950

subject_name: Mirtazapine


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: CHEBI:6950


subject: PUBCHEM.COMPOUND:11154555

subject_name: Cariprazine


subject: CHEBI:90933


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: diabetic neuropathy


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Hypoactive delirium


subject: CHEBI:16796

subject_name: Melatonin


subject: UNII:KXG2PJ551I

subject_name: Avelumab

object_name: Neoplasm, Residual


subject: UNII:KXG2PJ551I

object_name: adult acute myeloid leukemia


subject: UNII:KXG2PJ551I

object_name: childhood acute myeloid leukemia


subject: UNII:KXG2PJ551I

object_name: acute myeloid leukemia


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: UMLS:C3896806


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-


subject: PUBCHEM.COMPOUND:1805


subject: PUBCHEM.COMPOUND:1805


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:68841

subject_name: Gadobutrol

object_name: female reproductive organ cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Anesthetics adverse reaction


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: UMLS:C5241441

subject_name: chestnut extract

object_name: obesity due to melanocortin 4 receptor deficiency


subject: UMLS:C5241441

object_name: obesity


subject: UMLS:C5241441

object_name: Obesity, CTCAE


subject: UMLS:C1442791

subject_name: Chocolate antigen


subject: UMLS:C1442791


subject: UMLS:C1442791


subject: CHEMBL.COMPOUND:CHEMBL2108921

subject_name: CHOCOLATE


subject: CHEMBL.COMPOUND:CHEMBL2108921


subject: CHEMBL.COMPOUND:CHEMBL2108921


subject: UMLS:C2728194

subject_name: chocolate allergenic extract


subject: UMLS:C2728194


subject: UMLS:C2728194


subject: DRUGBANK:DB10977

subject_name: Cocoa


subject: DRUGBANK:DB10977


subject: DRUGBANK:DB10977


subject: UMLS:C0939909

subject_name: Theobroma cacao, cocoa, chocolate


subject: UMLS:C0939909


subject: UMLS:C0939909


subject: CHEMBL.COMPOUND:CHEMBL2107910

subject_name: OLIVE OIL


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: CHEMBL.COMPOUND:CHEMBL2107910


subject: GTOPDB:12889

subject_name: elranatamab

object_name: smoldering plasma cell myeloma


subject: UNII:L0HR9A577V

subject_name: Elranatamab


subject: UMLS:C4687515


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: diffuse large B-cell lymphoma


subject: UNII:CC9149U2QX

subject_name: Sodium ferric gluconate complex

object_name: chronic kidney disease


subject: UNII:CC9149U2QX

object_name: Chronic uremia


subject: UNII:CC9149U2QX

object_name: iron deficiency anemia


subject: UNII:FZ7NYF5N8L

subject_name: IRON SUCROSE


subject: UNII:FZ7NYF5N8L


subject: UNII:FZ7NYF5N8L


subject: CHEBI:192761

subject_name: Iron sucrose


subject: CHEBI:192761


subject: CHEBI:192761


subject: CHEBI:31824

subject_name: Mesna

object_name: acute lymphoblastic leukemia


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:30769

subject_name: Citric acid

object_name: Helicobacter pylori infection


subject: CHEMBL.COMPOUND:CHEMBL4297908

subject_name: CEVOSTAMAB

object_name: plasma cell myeloma


subject: UMLS:C4528565


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: CHEMBL.COMPOUND:CHEMBL2109379

object_name: primary biliary cholangitis


subject: UMLS:C5854509

subject_name: ADC 9MW2821

object_name: urothelial carcinoma


subject: UMLS:C5854509

object_name: transitional cell carcinoma


subject: GTOPDB:12989

subject_name: toripalimab


subject: GTOPDB:12989


subject: UNII:8JXN261VVA


subject: UNII:8JXN261VVA


subject: UMLS:C4329337

subject_name: TAB 001


subject: UMLS:C4329337


subject: PUBCHEM.COMPOUND:72995949

subject_name: Voclosporin

object_name: kidney disorder


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: CHEBI:4469

subject_name: dexamfetamine

object_name: Gambling


subject: CHEBI:5123

subject_name: Fluphenazine


subject: CHEBI:5613

subject_name: Haloperidol


subject: UMLS:C5555557

object_name: liver carcinoma


subject: CHEBI:233309

subject_name: Adagrasib

object_name: non-small cell lung carcinoma


subject: CHEBI:233309


subject: CHEBI:9667

subject_name: Triamcinolone

object_name: chronic obstructive pulmonary disease


subject: CHEBI:9667

object_name: lung disorder


subject: CHEBI:9667

object_name: obstructive lung disease


subject: UMLS:C0962969

subject_name: RAD 001

object_name: pancreatic neoplasm


subject: UMLS:C0962969

object_name: exocrine pancreatic carcinoma


subject: UMLS:C0962969

object_name: malignant pancreatic neoplasm


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: PUBCHEM.COMPOUND:70789204


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Mechanical ventilation finding


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: CHEBI:119915

subject_name: Fentanyl


subject: UNII:JJX4JHS4PO

object_name: Metastatic malignant neoplasm to pancreas


subject: UMLS:C2346687


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: late complication from liver transplant


subject: CHEBI:94463


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:8024

subject_name: Perindopril

object_name: Hypertension, CTCAE


subject: CHEBI:8024

object_name: type 2 diabetes mellitus


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:149509


subject: CHEBI:3347

subject_name: Candesartan


subject: CHEBI:3638

subject_name: Chloroquine


subject: UMLS:C0070286

subject_name: pentaglobulin


subject: CHEBI:3311

subject_name: Calcium carbonate

object_name: Bone fracture


subject: CHEBI:3311

object_name: Fractured


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL


subject: UNII:1C6V77QF41


subject: UNII:1C6V77QF41

object_name: osteoporosis


subject: UNII:1C6V77QF41

object_name: Encounter due to family history of osteoporosis


subject: UNII:1C6V77QF41

object_name: Osteoporosis, CTCAE 5.0


subject: UNII:1C6V77QF41

object_name: Osteoporosis, CTCAE 3.0


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:27300


subject: CHEBI:32696

object_name: Premature birth


subject: CHEBI:32696

object_name: Surgical procedure finding


subject: CHEBI:32696

object_name: malnutrition


subject: CHEBI:32696

object_name: Immune System and Related Disorders


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:16467


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Myelodysplasia


subject: CHEBI:63791

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:63791

object_name: childhood myelodysplastic syndrome


subject: CHEBI:63791

object_name: Myelodysplastic Syndrome, CTCAE


subject: UMLS:C2700362

subject_name: Lymphoseek

object_name: anus cancer


subject: UMLS:C2700362

object_name: anal carcinoma


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Dysphagia


subject: CHEBI:41879

object_name: Dysphagia, CTCAE


subject: CHEBI:41879

object_name: Respiratory complication


subject: CHEBI:119915

subject_name: Fentanyl


subject: CHEBI:119915


subject: CHEBI:119915


subject: CHEBI:7773

subject_name: Ondansetron


subject: CHEBI:7773


subject: CHEBI:7773


subject: CHEBI:44915

subject_name: Propofol


subject: CHEBI:44915


subject: CHEBI:44915


subject: CHEBI:9130

subject_name: Sevoflurane


subject: CHEBI:9130


subject: CHEBI:9130


subject: CHEBI:17045

subject_name: Nitrous oxide


subject: CHEBI:17045


subject: CHEBI:17045


subject: CHEBI:25805

subject_name: oxygen atom


subject: CHEBI:25805


subject: CHEBI:25805


subject: CHEBI:15379

subject_name: Oxygen


subject: CHEBI:15379


subject: CHEBI:15379


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: neuroendocrine neoplasm


subject: PUBCHEM.COMPOUND:91826462

object_name: advanced disease


subject: PUBCHEM.COMPOUND:91826462

object_name: pancreatic neoplasm


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: UNII:WJA5UO9E10

subject_name: Orelabrutinib

object_name: autoimmune thrombocytopenia


subject: UNII:WJA5UO9E10

object_name: thrombocytopenia due to immune destruction


subject: UNII:WJA5UO9E10

object_name: autoimmune thrombocytopenic purpura


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: neurofibromatosis 1


subject: PUBCHEM.COMPOUND:1805

object_name: neurofibromatosis type 1


subject: PUBCHEM.COMPOUND:1805

object_name: CBL-related disorder


subject: PUBCHEM.COMPOUND:1805

object_name: Noonan syndrome-like disorder with juvenile myelomonocytic leukemia


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:2038


subject: CHEBI:2038


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3367

object_name: juvenile myelomonocytic leukemia


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:75998

subject_name: Trametinib


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: CHEBI:75998


subject: UNII:NQX9KB6PCL

subject_name: Somatotropin

object_name: Congenital IGHD


subject: UNII:NQX9KB6PCL

object_name: Reduced circulating growth hormone concentration


subject: UNII:NQX9KB6PCL

object_name: Growth delay


subject: UMLS:C0169964

subject_name: somatropin


subject: UMLS:C0169964


subject: UMLS:C0169964


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: B-cell neoplasm


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:175901

subject_name: Gemcitabine


subject: UNII:06P3KLK2J8

subject_name: Glofitamab


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C5203254

subject_name: Rituximab Liquid Injection


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UMLS:C2987409


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:3160

subject_name: botulinum toxin type A

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:57505028

subject_name: Suvorexant

object_name: alcohol abuse


subject: PUBCHEM.COMPOUND:57505028

object_name: alcohol dependence


subject: CHEMBL.COMPOUND:CHEMBL4650442

object_name: Guillain-Barre syndrome


subject: UMLS:C5705578


subject: UMLS:C0085297

subject_name: immunoglobulins, intravenous


subject: CHEBI:151315

subject_name: Heparin

object_name: acute kidney failure


subject: KEGG.COMPOUND:C00374


subject: CHEBI:15552

subject_name: Epoprostenol


subject: UMLS:C4508898

object_name: Huntington disease


subject: CHEBI:134722

subject_name: Favipiravir

object_name: Hepatic impairment


subject: UMLS:C5848866

subject_name: Immunotherapy [APC]

object_name: HIV infection


subject: GTOPDB:13085

subject_name: adebrelimab


subject: UNII:1XBY50W1OX

subject_name: ADEBRELIMAB


subject: UMLS:C4725109


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab


subject: UMLS:C3827082


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox


subject: CHEBI:63716

subject_name: TENOFOVIR

object_name: Human immunodeficiency virus II infection


subject: PUBCHEM.COMPOUND:64987


subject: CHEBI:134504


subject: CHEBI:63625

subject_name: Tenofovir


subject: CHEBI:31536

subject_name: Emtricitabine


subject: CHEBI:63577

subject_name: Lamivudine


subject: CHEBI:31781

subject_name: Lopinavir


subject: CHEBI:45409

subject_name: Ritonavir


subject: CHEBI:82960

subject_name: Raltegravir


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: CHEBI:10110

subject_name: Zidovudine


subject: UMLS:C3491354

object_name: celiac disease


subject: UNII:J8435V445B

subject_name: Alicaforsen

object_name: inflammatory bowel disease


subject: UNII:J8435V445B

object_name: irritable bowel syndrome


subject: UNII:1K8M7UR6O1

subject_name: Yttrium Y-90

object_name: liver carcinoma


subject: UMLS:C1655276

subject_name: T-KI


subject: CHEBI:60787

subject_name: TIMOLOL

object_name: migraine


subject: CHEBI:60787

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:39465

subject_name: timolol


subject: CHEBI:39465


subject: CHEBI:231683

subject_name: Anakinra

object_name: juvenile idiopathic arthritis


subject: UNII:9013DUQ28K


subject: PR:000001137

subject_name: interleukin-1 receptor antagonist protein


subject: CHEBI:68646

subject_name: REGORAFENIB

object_name: Stage IIC Rectal Cancer AJCC v7


subject: CHEBI:68646

object_name: Stage IIC Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IIA Rectal Cancer AJCC v7


subject: CHEBI:68646

object_name: Stage IIA Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: stage IIB rectal cancer


subject: CHEBI:68646

object_name: Stage IIB Rectal Cancer AJCC v7


subject: CHEBI:68646

object_name: Stage IIB Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IIIB Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: Stage IIIB Rectal Cancer AJCC v7


subject: CHEBI:68646

object_name: Stage IIIA Rectal Cancer AJCC v7


subject: CHEBI:68646

object_name: Stage IIIA Rectal Cancer AJCC v8


subject: CHEBI:68646

object_name: stage IIIA rectal cancer


subject: CHEBI:68646

object_name: rectum adenocarcinoma


subject: CHEBI:68647

subject_name: Regorafenib


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: CHEBI:68647


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: infertility


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: CHEBI:8863

subject_name: Riluzole

object_name: frontotemporal dementia and/or amyotrophic lateral sclerosis 7


subject: CHEBI:8863

object_name: amyotrophic lateral sclerosis


subject: CHEBI:46058

subject_name: TAXOTERE

object_name: carcinoma of esophagus


subject: CHEBI:46058

object_name: esophageal cancer


subject: CHEBI:46058

object_name: Childhood Esophageal Carcinoma


subject: CHEBI:46058

object_name: neoplasm of esophagus


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:7514

subject_name: Neostigmine

object_name: Muscle Fatigue


subject: CHEBI:7514

object_name: Paresis


subject: CHEBI:7514

object_name: Muscle weakness


subject: CHEBI:73604

subject_name: Lys-Gly


subject: CHEBI:73604


subject: CHEBI:73604


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: Recurrent disease


subject: CHEBI:63791

object_name: Global Relapse in Viscera


subject: CHEBI:63791

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:63791

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:63791

object_name: Global Relapse


subject: CHEBI:63791

object_name: Global Relapse in Skin


subject: CHEBI:63791

object_name: Global Relapse in Blood


subject: CHEBI:63791

object_name: adult lymphoma


subject: CHEBI:63791

object_name: lymphoma


subject: CHEBI:63791

object_name: pediatric lymphoma


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C3640969

subject_name: Recombinant dimeric g-csf fusion protein f627

object_name: leukopenia


subject: UMLS:C3640969

object_name: neutropenia


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:DQ448MW7KS

subject_name: Palivizumab

object_name: respiratory syncytial virus infectious disease


subject: UMLS:C0672594

subject_name: MEDI 493


subject: UMLS:C0534628

subject_name: Endostatins

object_name: Neoplasm of cecum and/or colon and/or rectum


subject: UMLS:C0534628

object_name: colorectal neoplasm


subject: UMLS:C1705207

subject_name: Endostar


subject: UMLS:C1705207


subject: CHEBI:66901

subject_name: Ivacaftor

object_name: chronic rhinosinusitis


subject: CHEBI:114785

subject_name: Erlotinib

object_name: renal carcinoma


subject: CHEBI:114785

object_name: kidney neoplasm


subject: CHEBI:114785

object_name: kidney cancer


subject: CHEBI:38940

subject_name: Sunitinib


subject: CHEBI:38940


subject: CHEBI:38940


subject: CHEBI:119915

subject_name: Fentanyl

object_name: Critical Illness


subject: UMLS:C2346821

subject_name: pidilizumab

object_name: melanoma


subject: CHEBI:474053

subject_name: Cefazolin

object_name: puerperal infection


subject: UMLS:C0700930

subject_name: Cefamezine


subject: CHEBI:87681

subject_name: Ranolazine

object_name: pulmonary hypertension, primary, 1


subject: CHEBI:87681

object_name: pulmonary hypertension


subject: CHEBI:87681

object_name: idiopathic pulmonary arterial hypertension


subject: CHEBI:87681

object_name: pulmonary arterial hypertension


subject: CHEBI:87681

object_name: cardiovascular surgery result: angina


subject: PUBCHEM.COMPOUND:5273759

subject_name: Kivexa

object_name: HIV infection


subject: UMLS:C5435382


subject: CHEBI:90950

subject_name: Orkambi

object_name: cystic fibrosis


subject: RXCUI:1655924

subject_name: ivacaftor / lumacaftor Oral Product


subject: CHEBI:4856

subject_name: Esmolol

object_name: Stress Fracture


subject: CHEBI:4856

object_name: obstructive lung disease


subject: CHEBI:4856

object_name: catecholamine; overproduction


subject: UMLS:C3852764

subject_name: PEG-rhG-CSF

object_name: Childhood Breast Carcinoma


subject: UMLS:C3852764

object_name: breast carcinoma


subject: UMLS:C3852764

object_name: breast cancer


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: staphylococcus aureus infection


subject: UNII:420K487FSG

object_name: Nasal Polyp


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab

object_name: liver cancer


subject: UNII:QEN1X95CIX

object_name: liver neoplasm


subject: UNII:QEN1X95CIX

object_name: Adult Liver Carcinoma


subject: UNII:QEN1X95CIX

object_name: biliary tract neoplasm


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: CHEBI:7565

subject_name: Nifedipine

object_name: hypertension, pregnancy-induced


subject: CHEBI:7565

object_name: Maternal hypertension


subject: MESH:C433226

subject_name: twinrix

object_name: hepatitis B


subject: UNII:ZV5W411ZUU

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:ZV5W411ZUU

object_name: BRAF V600 Protein Variation


subject: UMLS:C5417837

subject_name: BRAF(V600E) Kinase Inhibitor ABM-1310


subject: UMLS:C5417837


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: CHEBI:52717

subject_name: Bortezomib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:52717

object_name: acute myeloid leukemia


subject: CHEBI:142406

subject_name: ziconotide

object_name: peripheral nervous system disorder


subject: CHEBI:142406

object_name: neuropathy


subject: PUBCHEM.COMPOUND:16135415

subject_name: Ziconotide


subject: PUBCHEM.COMPOUND:16135415


subject: CHEBI:131389

subject_name: magnesium citrate

object_name: Inflammation


subject: CHEBI:131389

object_name: type 2 diabetes mellitus


subject: CHEBI:131391


subject: CHEBI:131391


subject: UMLS:C5441887

subject_name: Ribes nigrum allergen

object_name: asthenopia


subject: UNII:4SY8H89134

subject_name: zircon

object_name: Hyperkalemia, CTCAE


subject: UNII:4SY8H89134

object_name: Hyperkalemia


subject: CHEBI:6402

subject_name: Leflunomide

object_name: IgA vasculitis


subject: CHEBI:3614

subject_name: Chlorhexidine

object_name: Wound Infection


subject: CHEBI:3614

object_name: Wound Infection, CTCAE


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:3745


subject: UMLS:C0054066

subject_name: amoxicillin / clavulanate


subject: UMLS:C0054066


subject: CHEBI:24859

subject_name: iodine atom


subject: CHEBI:24859


subject: CHEBI:17606

subject_name: Iodine


subject: CHEBI:17606


subject: UMLS:C0885449

subject_name: Iodine, Homeopathic preparation


subject: UMLS:C0885449


subject: PUBCHEM.COMPOUND:16170201

subject_name: TEICOPLANIN


subject: PUBCHEM.COMPOUND:16170201


subject: CHEBI:64089

subject_name: Vanoxerine

object_name: ATRIAL FIBRILLATION SYMPTOMATIC


subject: CHEBI:64089

object_name: atrial flutter


subject: CHEBI:64089

object_name: Atrial Flutter by ECG Finding


subject: CHEBI:64089

object_name: Atrial Flutter, CTCAE


subject: CHEBI:135926

subject_name: Udenafil

object_name: impotence


subject: CHEBI:135926

object_name: Erectile Dysfunction, CTCAE


subject: CHEBI:135926

object_name: Erectile dysfunction


subject: CHEBI:5931

subject_name: insulin human

object_name: Prediabetes


subject: UMLS:C0876064

subject_name: Lantus


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE


subject: UMLS:C1099192


subject: CHEBI:6801

subject_name: Metformin


subject: MESH:C000726310

object_name: familial hyperinsulinism


subject: MESH:C000726310

object_name: congenital isolated hyperinsulinism


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: post-traumatic stress disorder


subject: UMLS:C0592155

subject_name: Syntocinon


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus

object_name: Chronic rejection of cardiac transplant


subject: CHEMBL.COMPOUND:CHEMBL1743006

subject_name: DALOTUZUMAB

object_name: childhood neoplasm


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: neoplastic syndrome


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: cancer or benign tumor


subject: CHEMBL.COMPOUND:CHEMBL1743006

object_name: neoplasm


subject: UMLS:C2987605

subject_name: dalotuzumab


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UMLS:C2987605


subject: UNII:LOG73M21H5

subject_name: SUZETRIGINE

object_name: Diabetic peripheral neuropathic pain


subject: CHEBI:233446

subject_name: suzetrigine


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: malignant epithelial tumor of ovary


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:94771

subject_name: Quisinostat

object_name: ovarian carcinoma


subject: CHEBI:94771


subject: CHEBI:94771

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:5311453

subject_name: STA 2

object_name: Angina pectoris


subject: CHEBI:81579

subject_name: Erythropoietin

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:81579

object_name: myoclonic dystonia 11


subject: UMLS:C2981799

subject_name: edotreotide lutetium LU-177

object_name: neuroendocrine neoplasm


subject: UMLS:C2981799

object_name: lung neuroendocrine neoplasm


subject: UMLS:C2981799

object_name: thymus neoplasm


subject: PUBCHEM.COMPOUND:70789204

object_name: colorectal cancer


subject: PUBCHEM.COMPOUND:70789204

object_name: colorectal carcinoma


subject: PUBCHEM.COMPOUND:70789204

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: PUBCHEM.COMPOUND:70789204

object_name: colorectal neoplasm


subject: CHEBI:8988


subject: CHEBI:80630

subject_name: Irinotecan


subject: UNII:6A901E312A

subject_name: Panitumumab


subject: PUBCHEM.COMPOUND:18772499

subject_name: Inulin

object_name: Halitosis


subject: PUBCHEM.COMPOUND:18772499

object_name: tongue disorder


subject: UMLS:C2183198

subject_name: diagnostic drugs renal inulin


subject: UMLS:C2183198


subject: CHEBI:73653

subject_name: Ser-Ser


subject: CHEBI:73653


subject: UNII:2AD53WQ2CX

object_name: asthma


subject: CHEBI:63611

subject_name: Moxifloxacin


subject: CHEBI:94463

object_name: type 2 diabetes mellitus


subject: CHEBI:94463

object_name: Insulin resistance


subject: CHEBI:63580

subject_name: Ribavirin


subject: CHEBI:63580


subject: CHEBI:15365

subject_name: Aspirin

object_name: colon carcinoma


subject: CHEBI:15365

object_name: colon cancer


subject: PUBCHEM.COMPOUND:6096882

subject_name: indocyanine green

object_name: skin neoplasm


subject: PUBCHEM.COMPOUND:6096882

object_name: skin cancer


subject: UNII:C4V974V932

subject_name: Indocyanine green acid form


subject: UNII:C4V974V932


subject: UMLS:C3489691

subject_name: Betanis

object_name: Urinary Urgency


subject: UMLS:C2703101

subject_name: TRC102 Base

object_name: Solid Neoplasm


subject: UMLS:C2703101

object_name: lymphoma


subject: UMLS:C2703101

object_name: Metastatic Colon Carcinoma


subject: UMLS:C2703101

object_name: non-small cell lung carcinoma


subject: CHEBI:4672

subject_name: Docetaxel

object_name: Breast cancer stage II


subject: CHEBI:4672

object_name: Stage II Breast Cancer AJCC v6 and v7


subject: CHEBI:4672

object_name: Breast cancer stage III


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:175901


subject: UNII:85VMN9JU7A

subject_name: Ganaplacide

object_name: malaria


subject: UNII:6A901E312A

object_name: prostate carcinoma


subject: UNII:6A901E312A

object_name: prostate cancer


subject: CHEBI:4466

subject_name: Dexmedetomidine

object_name: Reperfusion Injury


subject: UNII:7N8K34P2XH

subject_name: Detomidine


subject: PUBCHEM.COMPOUND:71301229

subject_name: Xelox

object_name: rectal carcinoma


subject: PUBCHEM.COMPOUND:71301229

object_name: rectal cancer


subject: PUBCHEM.COMPOUND:71301229

object_name: Childhood Rectal Carcinoma


subject: UMLS:C5238912

subject_name: Anti-CD137 Agonistic Monoclonal Antibody AGEN2373

object_name: Advanced cancer


subject: CHEMBL.COMPOUND:CHEMBL4650435

subject_name: BOTENSILIMAB


subject: UMLS:C4764272

subject_name: Botensilimab


subject: CHEBI:8499

subject_name: Propranolol

object_name: migraine


subject: CHEBI:8499

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:10127

subject_name: Zonisamide


subject: CHEBI:10127


subject: PUBCHEM.COMPOUND:90199447

subject_name: TUVUSERTIB

object_name: Refractory Prostate Carcinoma


subject: PUBCHEM.COMPOUND:90199447

object_name: Stage IVB Prostate Cancer AJCC v8


subject: PUBCHEM.COMPOUND:90199447

object_name: castration-resistant prostate carcinoma


subject: PUBCHEM.COMPOUND:90199447

object_name: Metastatic castration-resistant prostate cancer


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: UNII:JE1BE6ZGZ7


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Hematoma, Subdural, Chronic


subject: CHEBI:41879

subject_name: Dexamethasone


subject: PUBCHEM.COMPOUND:44215723

subject_name: Rolapitant

object_name: Chemotherapy-induced nausea and vomiting


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Tourette syndrome


subject: PUBCHEM.COMPOUND:6026

subject_name: Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg

object_name: coronary artery disorder


subject: PUBCHEM.COMPOUND:6026

object_name: coronary atherosclerosis


subject: CHEBI:3165

subject_name: Bradykinin


subject: CHEBI:3165


subject: CHEBI:132988


subject: CHEBI:132988


subject: UNII:S8TIM42R2W

subject_name: BRADYKININ


subject: UNII:S8TIM42R2W


subject: UMLS:C0006100


subject: UMLS:C0006100


subject: UMLS:C1328058

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: UNII:QP166M390Q

subject_name: Ataciguat

object_name: intermittent vascular claudication


subject: UMLS:C1870724


subject: CHEBI:95067

subject_name: Iniparib

object_name: Childhood Breast Carcinoma


subject: CHEBI:95067

object_name: breast carcinoma


subject: CHEBI:95067

object_name: breast cancer


subject: CHEBI:52717

subject_name: Bortezomib

object_name: Mantle cell lymphoma stage I


subject: CHEBI:52717

object_name: Mantle cell lymphoma stage IV


subject: CHEBI:52717

object_name: Mantle cell lymphoma stage III


subject: CHEBI:52717

object_name: Ann Arbor Stage II Contiguous Mantle Cell Lymphoma


subject: CHEBI:52717

object_name: Ann Arbor Stage II Non-Contiguous Mantle Cell Lymphoma


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4026


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:41879


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: CHEBI:28748


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: UNII:3A58010674

subject_name: Pegfilgrastim


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:3A58010674


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:28445


subject: CHEBI:681848

subject_name: Doxapram

object_name: no feeling or sensation of skin


subject: CHEBI:681848

object_name: Sensory Loss


subject: UMLS:C5706553

subject_name: Anti-HER2 Antibody-drug Conjugate BL-M07D1

object_name: HER2 positive breast carcinoma


subject: UNII:4EQZ6YO2HI

subject_name: Denosumab

object_name: Osteopenia


subject: UMLS:C1530450

subject_name: AMG 162


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Recurrent Fallopian Tube Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Borderline Ovarian Mucinous Tumor


subject: UNII:2S9ZZM9Q9V

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: UNII:2S9ZZM9Q9V

object_name: Stage IA Ovarian Cancer


subject: UNII:2S9ZZM9Q9V

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:31348

subject_name: Capecitabine


subject: CHEBI:31348

object_name: Recurrent ovarian cancer


subject: CHEBI:31348

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:31348

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:31348

object_name: Borderline Ovarian Mucinous Tumor


subject: CHEBI:31348

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:31348

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:31348

object_name: Stage IA Ovarian Cancer


subject: CHEBI:31348

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:31355

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: CHEBI:31355


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805

object_name: Recurrent ovarian cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIIC Ovarian Cancer


subject: PUBCHEM.COMPOUND:43805

object_name: Borderline Ovarian Mucinous Tumor


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:43805

object_name: Stage IA Ovarian Cancer


subject: PUBCHEM.COMPOUND:43805

object_name: ovarian mucinous cystadenocarcinoma


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED

object_name: Recurrent Fallopian Tube Carcinoma


subject: UMLS:C1314429

object_name: Recurrent ovarian cancer


subject: UMLS:C1314429

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: UMLS:C1314429

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IA Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IC Fallopian Tube Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IIIC Ovarian Cancer


subject: UMLS:C1314429

object_name: Borderline Ovarian Mucinous Tumor


subject: UMLS:C1314429

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: UMLS:C1314429

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IC Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IB Ovarian Cancer AJCC v6 and v7


subject: UMLS:C1314429

object_name: Stage IA Ovarian Cancer


subject: UMLS:C1314429

object_name: ovarian mucinous cystadenocarcinoma


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:45863

object_name: Stage IB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: MESH:D007166

subject_name: Immunosuppressive Agents

object_name: scleritis


subject: MESH:D007166

object_name: uveitis


subject: MESH:D007166

object_name: Uveitis, CTCAE


subject: CHEBI:47381

subject_name: Diclofenac

object_name: Irreversible pulpitis


subject: UNII:8K80YB5GMG

subject_name: Rilonacept

object_name: scleroderma


subject: UNII:8K80YB5GMG

object_name: systemic sclerosis


subject: UNII:8K80YB5GMG

object_name: diffuse scleroderma


subject: UMLS:C2343505

subject_name: Arcalyst


subject: UMLS:C2343505


subject: UMLS:C2343505


subject: CHEBI:6801

subject_name: Metformin

object_name: prostate carcinoma


subject: CHEBI:6801

object_name: prostate cancer


subject: CHEBI:18258

subject_name: Liothyronine

object_name: secondary progressive multiple sclerosis


subject: CHEBI:18258

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:18258

object_name: primary progressive multiple sclerosis


subject: CHEBI:133021

subject_name: Venetoclax

object_name: cancer


subject: CHEBI:133021

object_name: childhood acute lymphoblastic leukemia


subject: CHEBI:133021

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:133021

object_name: childhood acute myeloid leukemia


subject: CHEBI:133021

object_name: non-Hodgkin lymphoma


subject: CHEBI:133021

object_name: Childhood Neuroblastoma


subject: CHEBI:133021

object_name: neuroblastoma


subject: UMLS:C3658787

object_name: HIV infection


subject: UMLS:C3658787

object_name: AIDS


subject: CHEBI:31348

object_name: benign neoplasm of pancreas


subject: CHEBI:31348

object_name: Pancreas problem


subject: CHEBI:31348


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805

object_name: neoplasm


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: Childhood Solid Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Adult Solid Neoplasm


subject: PUBCHEM.COMPOUND:14907381

object_name: Solid Neoplasm


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: CHEBI:46345


subject: CHEBI:31348


subject: CHEBI:31348


subject: CHEBI:31348


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: CHEBI:175901

subject_name: Gemcitabine


subject: CHEBI:175901


subject: CHEBI:191174

subject_name: Pteroyl-D-glutamic acid


subject: CHEBI:191174


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009

subject_name: Folinic acid


subject: PUBCHEM.COMPOUND:135402009


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: CHEBI:15640


subject: CHEBI:63606

subject_name: Levoleucovorin


subject: CHEBI:63606


subject: CHEBI:63606


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255


subject: MESH:C520255


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: PUBCHEM.COMPOUND:43805


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: UMLS:C1314429


subject: UMLS:C1314429


subject: CHEBI:231598

subject_name: Tazemetostat

object_name: follicular lymphoma


subject: PUBCHEM.COMPOUND:14907381

object_name: Metastatic malignant neoplasm to pancreas


subject: CHEBI:190410


subject: CHEBI:46345


subject: GTOPDB:9615


subject: UMLS:C3658787


subject: UNII:KXG2PJ551I

subject_name: Avelumab


subject: UMLS:C3896806


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab


subject: CHEBI:31348

subject_name: Capecitabine


subject: UMLS:C4722367


subject: DRUGBANK:DB17528


subject: DRUGBANK:DB17529


subject: DRUGBANK:DB17530


subject: UMLS:C4758796


subject: UNII:FIJ3OLQ3N8


subject: UMLS:C2826130

subject_name: Recombinant Saccharomyces Cerevisia-CEA(610D)-Expressing Vaccine GI-6207


subject: UMLS:C4722124


subject: UNII:B0L24T8TB7


subject: CHEBI:191174


subject: PUBCHEM.COMPOUND:135402009


subject: CHEBI:15640


subject: CHEBI:63606


subject: PUBCHEM.COMPOUND:43805


subject: UMLS:C1314429


subject: UMLS:C5777124

subject_name: CD-16 NK-92 cells


subject: UMLS:C4552849

subject_name: haNK


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Metastatic Breast Carcinoma


subject: CHEBI:4026

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:4026

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:4026

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:4026

object_name: Locally Advanced Unresectable Breast Carcinoma


subject: CHEBI:4026

object_name: Breast cancer recurrent


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:4027


subject: CHEBI:62880

subject_name: Veliparib


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:62880


subject: CHEBI:49603

subject_name: Lapatinib

object_name: Neck Carcinoma


subject: CHEBI:49603

object_name: head and neck neoplasm


subject: CHEBI:49603

object_name: head and neck cancer


subject: CHEBI:49603

object_name: squamous cell carcinoma


subject: UMLS:C5417868

subject_name: Perenostobart

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C5417868

object_name: prostate carcinoma


subject: UMLS:C5417868

object_name: prostate cancer


subject: UNII:W0ZE0NT8IF

subject_name: Etrumadenant


subject: UNII:W0ZE0NT8IF


subject: UNII:W0ZE0NT8IF


subject: GTOPDB:12349

subject_name: zimberelimab


subject: GTOPDB:12349


subject: GTOPDB:12349


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UNII:ZBL7O904IL


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: UMLS:C5204520


subject: CHEBI:7773

subject_name: Ondansetron

object_name: Compulsion


subject: CHEBI:7773

object_name: tic disorder


subject: CHEBI:7773

object_name: Tourette syndrome


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: small cell lung carcinoma


subject: CHEBI:6801

subject_name: Metformin

object_name: Adult Solid Neoplasm


subject: CHEBI:38545

subject_name: Rosuvastatin


subject: UMLS:C0812735

subject_name: INJECTION FLUCONAZOLE, 200 MG ADMINISTERED

object_name: inflammatory bowel disease 1


subject: UMLS:C0812735

object_name: Crohn disease


subject: CHEBI:46081

subject_name: Fluconazole


subject: CHEBI:46081


subject: CHEBI:62088

subject_name: Metamizole

object_name: Platelet aggregation test result


subject: UMLS:C0812735

object_name: Cryptococcal meningitis


subject: UMLS:C0812735

object_name: HIV infection


subject: CHEBI:46081


subject: CHEBI:46081


subject: CHEBI:41500

subject_name: Phenylbutyrates

object_name: spinal muscular atrophy, type 1


subject: UNII:06P3KLK2J8

subject_name: Glofitamab

object_name: adult lymphoma


subject: UNII:06P3KLK2J8

object_name: lymphoma


subject: UNII:06P3KLK2J8

object_name: pediatric lymphoma


subject: UMLS:C4725069

subject_name: glofitamab


subject: UMLS:C4725069


subject: UMLS:C4725069


subject: UNII:O43472U9X8

subject_name: Obinutuzumab


subject: UNII:O43472U9X8


subject: UNII:O43472U9X8


subject: UNII:I031V2H011

subject_name: Tocilizumab


subject: UNII:I031V2H011


subject: UNII:I031V2H011


subject: PUBCHEM.COMPOUND:155543961

subject_name: LIRAGLUTIDE

object_name: Parkinson disease


subject: UMLS:C1099192


subject: UMLS:C4525954

object_name: acute myeloid leukemia by FAB classification


subject: UMLS:C4525954

object_name: acute myeloid leukemia


subject: CHEBI:9150

subject_name: Simvastatin

object_name: Atrophy of alveolar ridges


subject: CHEBI:90620

subject_name: Vatalanib

object_name: Myelodysplasia


subject: CHEBI:90620

object_name: leukemia


subject: CHEBI:90620

object_name: childhood leukemia


subject: CHEBI:90620


subject: CHEBI:47781

subject_name: Desipramine

object_name: Depressed mood


subject: CHEBI:47781

object_name: Cancer patients and suicide and depression


subject: CHEBI:47781

object_name: Depressed - symptom


subject: CHEBI:47781

object_name: Depression, CTCAE


subject: PUBCHEM.COMPOUND:73265283

subject_name: Metenkephalin

object_name: pancreatic neoplasm


subject: PUBCHEM.COMPOUND:73265283

object_name: exocrine pancreatic carcinoma


subject: PUBCHEM.COMPOUND:73265283

object_name: malignant pancreatic neoplasm


subject: CHEBI:189868

subject_name: Metenkefalin


subject: CHEBI:189868


subject: CHEBI:189868


subject: UMLS:C1541553

subject_name: opioid growth factor


subject: UMLS:C1541553


subject: UMLS:C1541553


subject: CHEBI:167574

subject_name: Semaglutide

object_name: Dependence on dialysis due to end stage renal disease


subject: CHEBI:132922

object_name: Cognitive impairment


subject: CHEBI:132922

object_name: Primary malignant neoplasm


subject: CHEBI:132922

object_name: cancer


subject: CHEBI:132922

object_name: childhood malignant neoplasm


subject: CHEBI:132922

object_name: Malignant obstetric neoplasm


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:43415


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:5855


subject: CHEBI:85990

subject_name: Panobinostat

object_name: plasma cell myeloma


subject: UMLS:C1569697

object_name: malignant glioma


subject: UMLS:C1569697

object_name: glioblastoma


subject: UMLS:C1569697

object_name: Brain Stem Glioblastoma


subject: UMLS:C1569697

object_name: glioma susceptibility 1


subject: UMLS:C1569697

object_name: adult oligodendroglioma


subject: UMLS:C1569697

object_name: oligodendroglioma


subject: UMLS:C1569697

object_name: childhood oligodendroglioma


subject: UMLS:C1569697

object_name: Childhood Astrocytoma


subject: UMLS:C1569697

object_name: astrocytic tumor


subject: UMLS:C1569697

object_name: astrocytoma


subject: PUBCHEM.COMPOUND:53477758

subject_name: Oxytocin

object_name: Compulsion


subject: PUBCHEM.COMPOUND:53477758

object_name: body dysmorphic disorder


subject: UMLS:C0592155

subject_name: Syntocinon


subject: UMLS:C0592155


subject: CHEBI:17858

subject_name: oxiglutatione

object_name: Menopause present (finding)


subject: CHEBI:17858

object_name: Menopause


subject: CHEBI:17858

object_name: Heart Disease Risk Factors


subject: CHEBI:177535

subject_name: L-Glutathione (reduced)


subject: CHEBI:177535


subject: CHEBI:177535


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:57925


subject: CHEBI:177258

subject_name: Cytidine 2',3'-cyclic phosphate


subject: CHEBI:177258


subject: CHEBI:177258


subject: CHEBI:16856

subject_name: Glutathione


subject: CHEBI:16856


subject: CHEBI:16856


subject: CHEBI:16349

subject_name: Citrulline


subject: CHEBI:16349


subject: CHEBI:16349


subject: PUBCHEM.COMPOUND:152165

object_name: photosensitivity disease


subject: CHEBI:47381

subject_name: Diclofenac


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: recurrent respiratory papillomatosis


subject: CHEMBL.COMPOUND:CHEMBL4297728

subject_name: CIRMTUZUMAB

object_name: Metastatic castration-resistant prostate cancer


subject: UMLS:C3896753


subject: UMLS:C3272840

subject_name: meningococcal polysaccharide vaccine (MPSV4)

object_name: meningococcal infection


subject: UMLS:C3272840

object_name: meningitis


subject: UMLS:C3272840

object_name: Meningitis, CTCAE


subject: UMLS:C2960908

subject_name: Meningococcal vaccine component


subject: UMLS:C2960908


subject: UMLS:C2960908


subject: UNII:DA709Q5020

subject_name: zalutumumab

object_name: head and neck neoplasm


subject: UMLS:C1831978


subject: CHEBI:230682

subject_name: Indoximod

object_name: male breast carcinoma


subject: CHEBI:230682

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:230682

object_name: Carcinoma breast stage IV


subject: CHEBI:230682

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:230682

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:230682

object_name: Breast cancer recurrent


subject: CHEBI:230682

object_name: unspecified adult solid tumor, protocol specific


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: UMLS:C4045546


subject: CHEBI:15698

subject_name: Deoxycytidine


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: CHEBI:15698


subject: UMLS:C0042210

subject_name: Vaccines


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C0042210


subject: UMLS:C5399710

subject_name: Vaccine [APC]


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: UMLS:C5399710


subject: CHEBI:91397

subject_name: Ibrutinib

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:91397

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:91397

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:91397

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:91397

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:91397

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:91397

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:91397

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:91397

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:91397


subject: CHEBI:91397

object_name: Mantle cell lymphoma refractory


subject: CHEBI:91397

object_name: Follicular lymphoma refractory


subject: CHEBI:91397

object_name: Marginal zone lymphoma refractory


subject: CHEBI:91397

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:91397

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:91397

object_name: Follicular lymphoma recurrent


subject: CHEBI:91397

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:91397

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:91397

object_name: Richter syndrome


subject: CHEBI:93776

subject_name: Pevonedistat

object_name: Chronic lymphocytic leukaemia refractory


subject: CHEBI:93776

object_name: Non-Hodgkin's lymphoma refractory


subject: CHEBI:93776

object_name: Recurrent Chronic Lymphoid Leukemia


subject: CHEBI:93776

object_name: B-cell prolymphocytic leukemia


subject: CHEBI:93776

object_name: Recurrent Adult Non-Hodgkin Lymphoma


subject: CHEBI:93776

object_name: Recurrent Childhood Non-Hodgkin Lymphoma


subject: CHEBI:93776

object_name: Recurrent Non-Hodgkin Lymphoma


subject: CHEBI:93776

object_name: B-cell small lymphocytic lymphoma refractory


subject: CHEBI:93776

object_name: B-cell small lymphocytic lymphoma recurrent


subject: CHEBI:93776


subject: CHEBI:93776

object_name: Mantle cell lymphoma refractory


subject: CHEBI:93776

object_name: Follicular lymphoma refractory


subject: CHEBI:93776

object_name: Marginal zone lymphoma refractory


subject: CHEBI:93776

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:93776

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:93776

object_name: Follicular lymphoma recurrent


subject: CHEBI:93776

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:93776

object_name: Diffuse large B-cell lymphoma recurrent


subject: CHEBI:93776

object_name: Richter syndrome


subject: CHEBI:47519

subject_name: Ketoconazole

object_name: cryptorchidism


subject: CHEBI:47519

object_name: cryptorchidism (physical finding)


subject: CHEBI:81568

subject_name: luteinizing hormone


subject: CHEBI:81568


subject: UMLS:C1704298

subject_name: Recombinant Luteinizing Hormone


subject: UMLS:C1704298


subject: CHEBI:166975

subject_name: soybean oil

object_name: spontaneous abortion


subject: CHEBI:166975

object_name: habitual spontaneous abortion


subject: DRUGBANK:DB09422

subject_name: Soybean oil


subject: DRUGBANK:DB09422


subject: CHEBI:63918

subject_name: Artesunate

object_name: malaria


subject: UNII:7CS0WNO31M

subject_name: QUININE HYDROCHLORIDE


subject: CHEBI:137041


subject: CHEBI:15854

subject_name: Quinine


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Melanoma recurrent


subject: CHEBI:233158

subject_name: Soticlestat

object_name: Hepatic impairment


subject: UMLS:C2000258

object_name: non-small cell lung carcinoma


subject: UMLS:C3653316

subject_name: Vitamin K antagonists

object_name: Atrial fibrillation and flutter


subject: CHEBI:53766

subject_name: Acenocoumarol


subject: CHEBI:10033

subject_name: Warfarin


subject: UNII:AQK7UBA1LS

subject_name: Luspatercept

object_name: Myelodysplasia


subject: UNII:AQK7UBA1LS

object_name: Bone marrow myeloid dysplasia


subject: UMLS:C3641690


subject: UMLS:C3641690


subject: PUBCHEM.COMPOUND:4490623

object_name: cancer


subject: PUBCHEM.COMPOUND:4490623

object_name: neoplasm


subject: CHEBI:9506

subject_name: tetrodotoxin


subject: CHEBI:9506


subject: CHEBI:180459


subject: CHEBI:180459


subject: CHEBI:6015

subject_name: Isoflurane

object_name: hypotension


subject: CHEBI:6015

object_name: Hypotension, CTCAE


subject: CHEBI:73662

subject_name: Thr-Pro

object_name: Sleep Quality


subject: CHEBI:73662

object_name: Sleep Latency


subject: CHEBI:17347

subject_name: Testosterone


subject: CHEBI:17347


subject: PR:000029585

subject_name: lamina-associated polypeptide 2


subject: PR:000029585


subject: PR:000009721


subject: PR:000009721


subject: PR:000016875

subject_name: thymidine phosphorylase


subject: PR:000016875


subject: UMLS:C5444129

subject_name: Latent Membrane Protein 2


subject: UMLS:C5444129


subject: UMLS:C4726572

object_name: Neck Carcinoma


subject: UMLS:C4726572

object_name: head and neck neoplasm


subject: UMLS:C4726572

object_name: head and neck cancer


subject: UMLS:C4726572

object_name: malignant mesothelioma


subject: UMLS:C4726572

object_name: endometrial cancer


subject: UMLS:C4726572

object_name: uterine corpus cancer


subject: UMLS:C4726572

object_name: endometrial carcinoma


subject: UMLS:C4726572

object_name: skin squamous cell carcinoma


subject: UMLS:C4726572

object_name: cutaneous squamous cell carcinoma


subject: UMLS:C4726572

object_name: non-small cell lung carcinoma


subject: UMLS:C4726572

object_name: Hodgkin Disease


subject: UMLS:C4726572

object_name: Adult Classical Hodgkin Lymphoma


subject: UMLS:C4726572

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C4726572

object_name: clear cell renal carcinoma


subject: UMLS:C4726572

object_name: renal cell adenocarcinoma


subject: UMLS:C4726572

object_name: renal cell carcinoma


subject: UMLS:C4726572

object_name: trabecular adenocarcinoma


subject: UMLS:C4726572

object_name: cutaneous neuroendocrine carcinoma


subject: UMLS:C4726572

object_name: urothelial carcinoma


subject: UMLS:C4726572

object_name: transitional cell carcinoma


subject: UMLS:C4726572

object_name: small cell carcinoma


subject: UMLS:C4726572

object_name: non-Hodgkin lymphoma


subject: UMLS:C4726572

object_name: lung neoplasm


subject: UMLS:C4726572

object_name: melanoma


subject: GTOPDB:13676

subject_name: cosibelimab

object_name: Neck Carcinoma


subject: GTOPDB:13676

object_name: head and neck neoplasm


subject: GTOPDB:13676

object_name: head and neck cancer


subject: GTOPDB:13676

object_name: malignant mesothelioma


subject: GTOPDB:13676

object_name: endometrial cancer


subject: GTOPDB:13676

object_name: uterine corpus cancer


subject: GTOPDB:13676

object_name: endometrial carcinoma


subject: GTOPDB:13676

object_name: skin squamous cell carcinoma


subject: GTOPDB:13676

object_name: cutaneous squamous cell carcinoma


subject: GTOPDB:13676

object_name: non-small cell lung carcinoma


subject: GTOPDB:13676

object_name: Hodgkin Disease


subject: GTOPDB:13676

object_name: Adult Classical Hodgkin Lymphoma


subject: GTOPDB:13676

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:13676

object_name: clear cell renal carcinoma


subject: GTOPDB:13676

object_name: renal cell adenocarcinoma


subject: GTOPDB:13676

object_name: renal cell carcinoma


subject: GTOPDB:13676

object_name: trabecular adenocarcinoma


subject: GTOPDB:13676

object_name: cutaneous neuroendocrine carcinoma


subject: GTOPDB:13676

object_name: urothelial carcinoma


subject: GTOPDB:13676

object_name: transitional cell carcinoma


subject: GTOPDB:13676

object_name: small cell carcinoma


subject: GTOPDB:13676

object_name: non-Hodgkin lymphoma


subject: GTOPDB:13676

object_name: lung neoplasm


subject: GTOPDB:13676

object_name: melanoma


subject: UNII:PNW7GBB44P

subject_name: COSIBELIMAB

object_name: Neck Carcinoma


subject: UNII:PNW7GBB44P

object_name: head and neck neoplasm


subject: UNII:PNW7GBB44P

object_name: head and neck cancer


subject: UNII:PNW7GBB44P

object_name: malignant mesothelioma


subject: UNII:PNW7GBB44P

object_name: endometrial cancer


subject: UNII:PNW7GBB44P

object_name: uterine corpus cancer


subject: UNII:PNW7GBB44P

object_name: endometrial carcinoma


subject: UNII:PNW7GBB44P

object_name: skin squamous cell carcinoma


subject: UNII:PNW7GBB44P

object_name: cutaneous squamous cell carcinoma


subject: UNII:PNW7GBB44P

object_name: non-small cell lung carcinoma


subject: UNII:PNW7GBB44P

object_name: Hodgkin Disease


subject: UNII:PNW7GBB44P

object_name: Adult Classical Hodgkin Lymphoma


subject: UNII:PNW7GBB44P

object_name: nonpapillary renal cell carcinoma


subject: UNII:PNW7GBB44P

object_name: clear cell renal carcinoma


subject: UNII:PNW7GBB44P

object_name: renal cell adenocarcinoma


subject: UNII:PNW7GBB44P

object_name: renal cell carcinoma


subject: UNII:PNW7GBB44P

object_name: trabecular adenocarcinoma


subject: UNII:PNW7GBB44P

object_name: cutaneous neuroendocrine carcinoma


subject: UNII:PNW7GBB44P

object_name: urothelial carcinoma


subject: UNII:PNW7GBB44P

object_name: transitional cell carcinoma


subject: UNII:PNW7GBB44P

object_name: small cell carcinoma


subject: UNII:PNW7GBB44P

object_name: non-Hodgkin lymphoma


subject: UNII:PNW7GBB44P

object_name: lung neoplasm


subject: UNII:PNW7GBB44P

object_name: melanoma


subject: CHEBI:142432

subject_name: Vericiguat

object_name: Injury of kidney


subject: CHEBI:142432

object_name: aneurysm


subject: CHEBI:142432

object_name: vascular inflammations


subject: CHEBI:142432

object_name: brain disorder


subject: CHEBI:142432

object_name: coronary microvascular disorder


subject: CHEBI:6931

subject_name: Midazolam

object_name: liver cirrhosis


subject: CHEBI:44915

subject_name: Propofol


subject: UNII:317UBD60ML

subject_name: Pelcitoclax

object_name: neuroendocrine neoplasm


subject: CHEBI:32682

subject_name: L-argininium

object_name: end stage renal failure


subject: CHEBI:32682

object_name: Chronic uremia


subject: CHEBI:29952

subject_name: L-arginine residue


subject: CHEBI:29952


subject: CHEBI:16467

subject_name: Arginine


subject: CHEBI:16467


subject: UMLS:C2959379

subject_name: Indium (111-In) capromab pendetide

object_name: prostate carcinoma


subject: UMLS:C2959379

object_name: prostate cancer


subject: UMLS:C2703132


subject: UMLS:C2703132


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Depressive Symptoms


subject: CHEBI:75929

object_name: endogenous depression


subject: CHEBI:75929

object_name: major depressive disorder


subject: CHEBI:40009

subject_name: Cycloserine


subject: CHEBI:40009


subject: MESH:C476037

subject_name: PHY 906

object_name: Advanced Adult Hepatocellular Carcinoma


subject: MESH:C476037

object_name: adult hepatocellular carcinoma


subject: MESH:C476037

object_name: liver carcinoma


subject: MESH:C476037

object_name: BCLC Stage C Adult Hepatocellular Carcinoma


subject: MESH:C476037

object_name: BCLC Stage B Adult Hepatocellular Carcinoma


subject: MESH:C476037

object_name: advanced adult primary liver cancer


subject: PUBCHEM.COMPOUND:131769963

subject_name: Digoxigenin monodigitoxoside


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: PUBCHEM.COMPOUND:131769963


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: UNII:5XYK65KIGD


subject: CHEBI:50924

subject_name: Sorafenib


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:50924


subject: CHEBI:141969

subject_name: Tipifarnib

object_name: Melanoma recurrent


subject: CHEBI:141969

object_name: Metastatic Cutaneous Melanoma


subject: CHEBI:141969

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: CHEBI:141969

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:148193

subject_name: Tonapofylline


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: PUBCHEM.COMPOUND:148193


subject: CHEBI:7009

subject_name: Moxonidine

object_name: Osteopenia


subject: UMLS:C1519138

object_name: plasma cell myeloma


subject: UNII:B96UX1DDKS

subject_name: Gemcabene

object_name: Hypercholesterolemia


subject: GTOPDB:5962

subject_name: dovitinib

object_name: adrenal cortex carcinoma


subject: GTOPDB:5962

object_name: adenoid cystic carcinoma


subject: UNII:69VKY8P7EA


subject: UNII:69VKY8P7EA


subject: UMLS:C2004126

subject_name: TKI 258


subject: UMLS:C2004126


subject: CHEBI:177770

subject_name: Ganetespib

object_name: non-small cell lung carcinoma


subject: PUBCHEM.COMPOUND:126456119

subject_name: Lactoferrin

object_name: iron deficiency anemia


subject: PR:000009978

subject_name: lactotransferrin


subject: UMLS:C0022942

subject_name: lactoferrin


subject: UniProtKB:Q8TCD2

subject_name: LTF protein, human


subject: CHEBI:43796

subject_name: (S)-lipoic acid

object_name: diabetic polyneuropathy


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: Solid Neoplasm


subject: CHEBI:84040

object_name: Fatty Liver


subject: CHEBI:36002

subject_name: cis-resveratrol


subject: CHEBI:27881

subject_name: resveratrol


subject: PUBCHEM.COMPOUND:4695

subject_name: Isosulfan blue

object_name: stage I cervical cancer


subject: PUBCHEM.COMPOUND:4695

object_name: Stage I Cervical Cancer AJCC v6 and v7


subject: PUBCHEM.COMPOUND:4695

object_name: Stage I Cervical Cancer AJCC v8


subject: PUBCHEM.COMPOUND:4695

object_name: cervical adenocarcinoma


subject: PUBCHEM.COMPOUND:4695

object_name: cervical squamous cell carcinoma


subject: PUBCHEM.COMPOUND:4695

object_name: cervical adenosquamous carcinoma


subject: UNII:39N9K8S2A4

subject_name: isosulfan blue


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:39N9K8S2A4


subject: UNII:T42P99266K

subject_name: METHYLENE BLUE


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: UNII:T42P99266K


subject: CHEBI:43830

subject_name: Methylthioninium


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: CHEBI:43830


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: acute leukemia


subject: PUBCHEM.COMPOUND:596

object_name: KMT2A Gene Rearrangement


subject: PUBCHEM.COMPOUND:596

object_name: acute myeloid leukemia with mutated NPM1


subject: PUBCHEM.COMPOUND:596

object_name: NPM1 gene mutation


subject: PUBCHEM.COMPOUND:596

object_name: Neoplasms by Histologic Type


subject: PUBCHEM.COMPOUND:596

object_name: hematopoietic and lymphoid cell neoplasm


subject: PUBCHEM.COMPOUND:596

object_name: hematopoietic and lymphoid system neoplasm


subject: PUBCHEM.COMPOUND:596

object_name: Malignant tumor of lymphoid hemopoietic and related tissue


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: PUBCHEM.COMPOUND:3367

object_name: myeloid leukemia


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:145372

subject_name: Gilteritinib

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:145372

object_name: leukemia


subject: CHEBI:145372

object_name: childhood leukemia


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: CHEBI:145372


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: CHEBI:42068


subject: UNII:4MOD1F4ENC

subject_name: Ziftomenib


subject: UNII:4MOD1F4ENC

object_name: acute myeloid leukemia


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: UNII:4MOD1F4ENC


subject: CHEBI:37956

subject_name: histamine antagonist

object_name: irritable bowel syndrome


subject: CHEBI:37956

object_name: dermatographia


subject: CHEBI:37956

object_name: Postprandial diarrhea


subject: UMLS:C0740098

subject_name: Antihistamine brand of Diphenhydramine


subject: UMLS:C0740098


subject: UMLS:C0740098


subject: UMLS:C0019592

subject_name: Histamine H1 Antagonists


subject: UMLS:C0019592


subject: UMLS:C0019592


subject: UMLS:C3536809

subject_name: Antihistamine [EPC]


subject: UMLS:C3536809


subject: UMLS:C3536809


subject: CHEBI:93775

subject_name: Amethopterin

object_name: psoriatic arthritis


subject: CHEBI:50681


subject: CHEBI:44185

subject_name: Methotrexate


subject: CHEBI:36704

subject_name: Imiquimod

object_name: Lentigo Maligna


subject: CHEMBL.COMPOUND:CHEMBL5314371

subject_name: MANGANESE CHLORIDE

object_name: adult lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: pediatric lymphoma


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: Childhood Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: Adult Solid Neoplasm


subject: CHEMBL.COMPOUND:CHEMBL5314371

object_name: Solid Neoplasm


subject: CHEBI:86368

subject_name: LumenHance


subject: CHEBI:86368


subject: CHEBI:86368


subject: CHEBI:86368


subject: CHEBI:86368


subject: CHEBI:86368


subject: CHEBI:73604

subject_name: Lys-Gly

object_name: colorectal cancer


subject: CHEBI:73604

object_name: colorectal carcinoma


subject: CHEBI:73604

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:16856

subject_name: Glutathione

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:51038893

subject_name: Cobimetinib


subject: PUBCHEM.COMPOUND:51038893


subject: PUBCHEM.COMPOUND:51038893


subject: UMLS:C0813973

subject_name: Medical Marijuana

object_name: Drug Resistant Epilepsy


subject: CHEBI:7640

subject_name: Nortriptyline

object_name: Depressed mood


subject: CHEBI:7640

object_name: Cancer patients and suicide and depression


subject: CHEBI:7640

object_name: Depressed - symptom


subject: CHEBI:7640

object_name: Depression, CTCAE


subject: UMLS:C3248676

subject_name: ONDANSETRON, ORAL, 4 MG (FOR CIRCUMSTANCES FALLING UNDER THE MEDICARE STATUTE, USE HCPCS Q CODE)

object_name: post operative nausea and vomiting


subject: CHEBI:28197

subject_name: Daidzein

object_name: type 2 diabetes mellitus


subject: CHEBI:77764


subject: CHEBI:74224


subject: CHEBI:27514

subject_name: genistin


subject: CHEBI:28088

subject_name: Genistein


subject: UMLS:C3827097

object_name: plasma cell myeloma


subject: UMLS:C3827097

object_name: AL amyloidosis


subject: CHEBI:233362

subject_name: Abemaciclib

object_name: Advanced breast cancer


subject: CHEBI:50790

subject_name: EC 1.14.14.14 (aromatase) inhibitor


subject: UMLS:C0593802

subject_name: Aromatase Inhibitors


subject: UNII:6XC1PAD3KF

subject_name: ZOLEDRONIC ACID

object_name: beta thalassemia


subject: UNII:6XC1PAD3KF

object_name: beta-thalassemia HBB/LCRB


subject: CHEBI:46557

subject_name: Zoledronic acid


subject: CHEBI:46557


subject: UMLS:C1527137

subject_name: Recombinant melatonin

object_name: Consciousness Disorders


subject: CHEBI:16796

subject_name: Melatonin


subject: PUBCHEM.COMPOUND:4240

subject_name: Mometasone furoate

object_name: Nasal Polyp


subject: CHEBI:6970

subject_name: Mometasone


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: diffuse large B-cell lymphoma


subject: CHEBI:63791

object_name: Adult Diffuse Large B-Cell Lymphoma


subject: CHEBI:63791

object_name: Childhood Diffuse Large B-Cell Lymphoma


subject: UNII:QQA9MLH692

subject_name: Tafasitamab


subject: UNII:QQA9MLH692


subject: UNII:QQA9MLH692


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: UMLS:C2987409


subject: PUBCHEM.COMPOUND:74030550

subject_name: Sugammadex

object_name: General anesthetic drug adverse reaction


subject: CHEBI:42567

subject_name: Fisetin

object_name: osteoarthritis, knee


subject: CHEBI:42567

object_name: Depressed mood


subject: CHEBI:42567

object_name: Cancer patients and suicide and depression


subject: CHEBI:42567

object_name: Depressed - symptom


subject: CHEBI:42567

object_name: Depression, CTCAE


subject: CHEBI:42567

object_name: obesity


subject: GTOPDB:9592

subject_name: tislelizumab

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: UMLS:C4053664


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Stress urinary incontinence


subject: CHEMBL.COMPOUND:CHEMBL183041

subject_name: Tipranavir

object_name: HIV infection


subject: CHEBI:91951

object_name: breast neoplasm


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: PUBCHEM.COMPOUND:21634109

subject_name: Lacosamide

object_name: epilepsy


subject: PUBCHEM.COMPOUND:10011857

subject_name: Fluorocholine F-18

object_name: breast carcinoma


subject: UMLS:C1872806


subject: CHEBI:31797

subject_name: Gadolinium DTPA


subject: CHEBI:180856

subject_name: Hovenoside G


subject: UMLS:C0721529

subject_name: Magnevist


subject: CHEBI:7986

subject_name: Pentoxifylline


subject: UMLS:C5202845

subject_name: Tandem Mass Tag

object_name: Muscle Invasive Bladder Carcinoma


subject: UMLS:C5202845

object_name: neoplasm